Therapeutic and Prophylactic Effect of Triludan on Japanese Cedar Pollinosis.
نویسندگان
چکیده
منابع مشابه
Prophylactic Sublingual Immunotherapy for Japanese Cedar Pollinosis
Sublingual immunotherapy is much safer than conventional percutaneous immunotherapy. This is the only treatment available which can completely cure the disease. A randomized, placebocontrolled, double-blind study has revealed that sublingual immunotherapy is both effective and safe for the patient with this pollinosis [3]. Only recently, standardized Japanese cedar pollen extract became availab...
متن کاملMinimal persistent inflammation in Japanese cedar pollinosis and a prophylactic effect of intranasal corticosteroids
Background Low doses of allergen exposure can cause an activation of inflammatory cells in nasal mucosa without an onset of nasal symptoms, called MPI (minimal persistent inflammation). MPI contributes to hyperreactivity and subsequently onset of the full-scale symptom. However, little is known whether MPI is present in JCP (Japanese cedar pollinosis). In addition, a prophylactic effect of intr...
متن کاملAsthma in Patients With Japanese Cedar Pollinosis
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea, nasal obstruction, nasal itching, and itching of the eyes. Previous reports indicate that the prevalence of Japanese cedar pollinosis among Japane...
متن کاملJapanese cedar pollinosis: Discovery, nomenclature, and epidemiological trends
The history of pollinosis in Japan before the discovery of Japanese cedar pollinosis was presented in part I in this paper. Until early 1960s, it was believed that there was no pollinosis in Japan except one case of ragweed pollinosis. The summary of how the Japanese cedar pollinosis was discovered and named was presented in part II, by referring to the paper in which we reported the presence o...
متن کاملAnti-IgE antibody therapy for Japanese cedar pollinosis: omalizumab update.
Seasonal allergic rhinitis (SAR) induced by Japanese cedar pollens is a substantial problem in Japan. Omalizumab, a novel humanized monoclonal anti-immunoglobulin E (IgE) antibody, has already been proven to reduce symptoms associated with SAR. To investigate the safety and efficacy of omalizumab in the treatment of patients with Japanese cedar pollen-induced SAR compared to placebo or anti-all...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Practica Oto-Rhino-Laryngologica
سال: 1993
ISSN: 1884-4545,0032-6313
DOI: 10.5631/jibirin.86.135